A COMPARISON OF XELIRI PLUS BEVACIZUMAB WITH FOLFIRI PLUS BEVACIZUMAB AS FIRST-LINE SETTING IN PATIENTS WITH METASTATIC COLORECTAL CANCER

Ahmet B., UYGUN K., Kaya S., Ustaalioglu B. B. O., Yildiz R., Temiz S., ...More

14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 - 30 June 2012, vol.23, pp.98-99, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 23
  • City: Barcelona
  • Country: Spain
  • Page Numbers: pp.98-99
  • Kocaeli University Affiliated: Yes